Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of 3.52% is 100% above its 3-year average of -6009.49%, near the high end of its 3-year range (-24025.24%–3.52%).
103.47% above its 12-month average of 1.73%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): 0.60%.
RETURN ON ASSETS (ROA)
3.52%
RETURN ON ASSETS (ROA) AVG TTM
1.73%
RETURN ON ASSETS (ROA) AVG 3Y
-6009.49%
RETURN ON ASSETS (ROA) AVG 5Y
N/A
RETURN ON ASSETS (ROA) AVG 10Y
N/A
RETURN ON ASSETS (ROA) AVG 15Y
N/A
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
+103.47%
CURRENT VS 3Y AVG
+100.06%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · FINANCIAL SERVICES
1.23%
median of 710 covered companies
CURRENT VS SECTOR MEDIAN
+185.02%
vs the sector median at left
Translational Development Acquisition Corp.
Market Cap
$266.99M
Return on Assets (ROA)
3.52%
TTM Avg
1.73%
3Y Avg
-6009.49%
5Y Avg
N/A
Market Cap
$267.82M
Return on Assets (ROA)
0.01%
TTM Avg
6.95%
3Y Avg
1.23%
5Y Avg
0.50%
Market Cap
$266.05M
Return on Assets (ROA)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$265.95M
Return on Assets (ROA)
1.49%
TTM Avg
1.13%
3Y Avg
0.85%
5Y Avg
0.91%
Market Cap
$268.25M
Return on Assets (ROA)
1.10%
TTM Avg
0.80%
3Y Avg
0.83%
5Y Avg
0.93%
Market Cap
$264.76M
Return on Assets (ROA)
3.27%
TTM Avg
1.79%
3Y Avg
1.79%
5Y Avg
1.79%
Market Cap
$264.47M
Return on Assets (ROA)
3.34%
TTM Avg
2.20%
3Y Avg
2.20%
5Y Avg
2.20%
Market Cap
$264.38M
Return on Assets (ROA)
4.15%
TTM Avg
-42.24%
3Y Avg
-42.24%
5Y Avg
-42.24%
Market Cap
$270.05M
Return on Assets (ROA)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Translational Development Acquisition Corp. (TDAC) | $266.99M | 3.52% | 1.73% | -6009.49% | N/A |
| Kingstone Companies, Inc. (KINS)vs › | $267.82M | 0.01% | 6.95% | 1.23% | 0.50% |
| Thunder Bridge Capital Partners V L (TBCVU)vs › | $266.05M | N/A | N/A | N/A | N/A |
| Hawthorn Bancshares, Inc. (HWBK)vs › | $265.95M | 1.49% | 1.13% | 0.85% | 0.91% |
| LCNB Corp. (LCNB)vs › | $268.25M | 1.10% | 0.80% | 0.83% | 0.93% |
| Oaktree Acquisition Corp. II (OACC)vs › | $264.76M | 3.27% | 1.79% | 1.79% | 1.79% |
| ProCap Acquisition Corp (PCAP)vs › | $264.47M | 3.34% | 2.20% | 2.20% | 2.20% |
| Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA)vs › | $264.38M | 4.15% | -42.24% | -42.24% | -42.24% |
| Cartesian Growth Corp. Iv (CGCF)vs › | $270.05M | N/A | N/A | N/A | N/A |
| Soren Acquisition Corp. (SORN)vs › | $263.53M | 1.23% | -16.10% | -16.10% | -16.10% |
ROA
3.5%
ROE
3.7%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | 3.50% |
| 2024-12-31 | -0.04% |
| 2023-12-31 | -24025.24% |
| 2022-12-31 | -16.16% |
